Updates from Isomorphic Labs
An AI-first drug discovery company reimagining the design of medicines from first principles to solve all disease.
- Isomorphic Labs joins the Virtual Biology Initiative to build foundational data for AI models to predict and treat dise… (Partnership · October 7, 2026)
Isomorphic Labs joined an international cross-sector initiative to generate and share AI-ready biological data, aiming to build foundational models for predicting and treating human diseases. - Building a new path to make medicines with AI (Company update · September 29, 2026)
The company detailed its shift toward approaching drug discovery as an engineering discipline, utilizing foundation models and generative design agents to understand molecular health and disease… - Isomorphic Labs Enters into a Research Collaboration with Johnson & Johnson (Partnership · January 20, 2026)
Isomorphic Labs entered into a multi-target research collaboration to identify novel molecules and develop new therapeutics across various modalities, including small molecules and biologics.